Photon-counting CT-derived hepatic extracellular volume quantification for noninvasive risk stratification of clinically significant portal hypertension (CSPH): a prospective cohort study

Question Can a quantitative biomarker from routine CT scans reliably stratify risk for clinically significant portal hypertension, overcoming limitations of current noninvasive methods? Findings Photon-counting CT-derived ECV accurately stratifies portal hypertension risk, offering high sensitivity (95%) for rule-in and high specificity (97%) for rule-out. Clinical relevance Integrating PCCT-ECV into routine surveillance CT provides an opportunistic, noninvasive tool for CSPH risk stratification, guiding timely patient management without requiring a separate examination.

Authors

Institutions

Publication Details

Journal
European Radiology
Published
2025-12-23
DOI
https://doi.org/10.1007/s00330-025-12222-8
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Photon-counting CT-derived hepatic extracellular volume quantification for noninvasive risk stratification of clinically significant portal hypertension (CSPH): a prospective cohort study

Daniel Kuetting, Verena Tischler, Julian Alexander Luetkens, Tatjana Dell et al.
European Radiology
Liver Disease Diagnosis and Treatment
article

Photon-counting CT-derived hepatic extracellular volume quantification for noninvasive risk stratification of clinically significant portal hypertension (CSPH): a prospective cohort study

Daniel Kuetting, Verena Tischler, Julian Alexander Luetkens, Tatjana Dell, Dario Zocholl, Claus Christian Pieper, Narine Mesropyan, Alexander Isaak, Patrick Arthur Kupczyk, Johannes Chang, Bernhard T. Schmidt, Abraham Jacob, Christian Strassburg, Christian Jansen, Carsten Meyer
article en

Abstract

Question Can a quantitative biomarker from routine CT scans reliably stratify risk for clinically significant portal hypertension, overcoming limitations of current noninvasive methods? Findings Photon-counting CT-derived ECV accurately stratifies portal hypertension risk, offering high sensitivity (95%) for rule-in and high specificity (97%) for rule-out. Clinical relevance Integrating PCCT-ECV into routine surveillance CT provides an opportunistic, noninvasive tool for CSPH risk stratification, guiding timely patient management without requiring a separate examination.

European Radiology
University of Bonn (DE), University Hospital Bonn (DE), Institut für Medizinische Biometrie, Informatik und Epidemiologie (DE), Siemens Healthineers (Germany) (DE)
Good health and well-being
Openalex Percentile: Top 31%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Photon-counting CT-derived hepatic extracellular volume quantification for noninvasive risk stratification of clinically significant portal hypertension (CSPH): a prospective cohort study — Daniel Kuetting, Verena Tischler, et al. · European Radiology (2025) | TGRS Research Map | TGRS